OQS
BIOC

Occudo Quantitative Strategies’s Biocept, Inc. BIOC Stock Holding History

Occudo Quantitative Strategies’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-955
Closed -$104K – 1384
2021
Q4 		$104K Sell
955
-777
-45% -$89.5K 0.01% 954
2021
Q3 		$208K Buy
+1,732
New +$202K 0.02% 852
2021
Q1 		– Sell
-1,038
Closed -$138K – 976
2020
Q4 		$138K Buy
+1,038
New +$148K 0.04% 578

Other funds holding BIOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Occudo Quantitative Strategies's BIOC Position: Q1 2022 in Review

Occudo Quantitative Strategies sold out of Biocept, Inc. (BIOC) in Q1 2022, closing a stake of 955 shares — an estimated $104K sold.

Occudo Quantitative Strategies first reported a position in BIOC in Q4 2020 and held it in 3 quarters. The position peaked at $208K in Q3 2021. 27 funds tracked by Wall St. Rank hold BIOC as of Q1 2022.

  • Occudo Quantitative Strategies reported no remaining Biocept, Inc. position as of Q1 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 955 Biocept, Inc. shares in Q1 2022, an estimated $104K.
  • Occudo Quantitative Strategies first reported a position in Biocept, Inc. in Q4 2020 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Biocept, Inc. position peaked at $208K in Q3 2021.
  • 27 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2022, filed 16 May 2022.